juno therapeutics
TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform
May 28, 2025Mergers and Acquisitions Cell and Gene Therapy (CGT), Corporate, Juno GmbH, TQ Therapeutics, juno therapeutics
TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno …
Juno CEO and Co-founder steps down in wake of Celgene acquisition
April 25, 2018Medical Communications, Research and Development Celgene, appointment, juno therapeutics, pharma
Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
Read Pharmafocus January/February 2018 edition online now!
January 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation
With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine …
Celgene confirms rumours, with $9bn deal for Juno
January 22, 2018Manufacturing and Production, Sales and Marketing CAR-T, Celgene, biotech, drugs, juno therapeutics, pharma, pharmaceutical
It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …
Top Ten most popular articles on Pharmafile.com this week
January 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten
It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …
Ex-Genentech exec named as new Juno Therapeutics CIO
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics
Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …
Juno Therapeutics bring in new executive vice president
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics
Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …
Patient deaths lead Juno Therapeutics to halt trial for second time
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics
Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …
Weekly Movers: CytRx, Coherus BioSciences, Juno Therapeutics…
July 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coherus BioSciences, GW Pharmaceuticals, Sage Therapeutics, Share price, Shares, Stock Markets, cytrx, juno therapeutics
Shares in CytRx (Nasdaq: CYTR) lost nearly three-fourth in value after the company reported disappointing late-stage results for its lead …
Busy week at Juno Therapeutics ends with takeover of RedoxTherapies
July 15, 2016Medical Communications, Research and Development, Sales and Marketing juno therapeutics, redoxtherapies, takeover, vipadenant
Juno Therapeutics (NASDAQ: JUNO) has announced the acquisition of RedoxTherapies, adding its lead cancer drug candidate, vipadenant, to its portfolio.
US FDA lifts hold on Juno’s CAR-T therapy trials; shares jump
July 13, 2016Research and Development, Sales and Marketing Stock Price, US FDA, drug trial, juno therapeutics
Shares in Juno Therapeutics (Nasdaq: JUNO) jumped to close up almost 30% after the company said the US Food and …
Weekly Movers: Medivation, Bind Therapeutics, Insys…
July 11, 2016Manufacturing and Production, Research and Development, Sales and Marketing Medivation, XBiotech, juno therapeutics, markets, stocks
Medivation (Nasdaq: MDVN) stock rose after the company announced it has entered a confidentiality agreement with a number of parties …
FDA suspends Juno Therapeutics cancer drug trial after patient deaths
July 8, 2016Medical Communications, Research and Development FDA, juno therapeutics, patient deaths
Juno Therapeutics (NASDAQ: JUNO) has had its Phase II trial investigating JCAR015 in adult patients with relapsed or refractory B …
